Correvio Pharma (CORV) Stock: Headed Up On NDA Resubmission Plans
Correvio Pharma Corp (NASDAQ: CORV) is having an incredibly strong day in the market today, and for good reason. The company said that it intends on refiling a New Drug Application with the FDA. Of course, the news led to excitement among investors, sending the stock screaming for the top. Today, we’ll talk about: The … Read more